South and Central America Asthma Drugs Market

The South and Central America asthma drugs market is expected to reach US$ 2,672.86 million by 2028 from US$ 1,863.99 million in 2021; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.

The growth of the market is due to the rising prevalence of asthma and the increasing research activities and product innovations are propelling the asthma drugs market growth. However, the unmet medical needs are hampering market growth.

Asthma is a chronic respiratory condition marked by fluctuating airflow restriction, bronchial hyperresponsiveness, and airways inflammation. According to a review paper titled “Impact of Air Pollution on Asthma Outcomes” by Tiotiu et.al., air pollution hampered asthma outcomes in adults and children. Air pollution from traffic, nitrogen dioxide (NO2), and secondhand smoking (SHS) are all substantial risk factors for the development of asthma in children. Asthma symptoms, exacerbations, and decreased lung function can be triggered by exposure to outside pollution.

A new study financed by the Environmental Protection Agency (EPA) analyzed the link between air pollution and asthma. While experts cannot determine the primary asthma-causing agent due to air pollution, evidence suggests that it suppresses genes that control the immune system to distinguish between an allergen and a hazardous foreign substance, such as a virus or bacteria. The immune system then goes into overdrive, triggering an inflammatory reaction regardless of whether the drug is toxic, resulting in asthma.

Researchers from Stanford University's Children's Center investigated the effect of air pollution on two genes involved in immunological tolerance in children from an area with high levels of pollution. They discovered that short- and long-term exposure to high amounts of carbon monoxide (CO), NO2, and PM2.5 (particulate matter) were linked to changes in these two genes, which caused asthma. These findings focused on the epigenetic impacts of air pollution exposure and could help in the development of preventative asthma medicines.

Each of these asthma research has improved the understanding of asthma in children and supplied crucial information to the EPA that can be used to protect human health and the environment. Through these research works, the drug discovery and development for asthma is being expedited which is driving the asthma drug market.

 South and Central America Asthma Drugs Market Revenue and Forecast to 2028 (US$ Mn)

Get more information on this report Request Free Sample PDF

South and Central America Asthma Drugs Strategic Insights

Strategic insights for the South and Central America Asthma Drugs provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South and Central America Asthma Drugs Report Scope

South and Central America Asthma Drugs Regional Insights

The geographic scope of the South and Central America Asthma Drugs refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

SOUTH AND CENTRAL AMERICA ASTHMA DRUGS MARKET SEGMENTATION

The South and Central America asthma drugs market, by medication, is segmented into quick relief medications and long-term control medications. Based on route of administration, the South and Central America asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others.  Based on distribution channel, the South and Central America asthma drugs market is segmented into online pharmacies, hospital pharmacies, retail pharmacies and drugstores Geographically, the South and Central America asthma drugs market is divided into Brazil, Argentina and Rest of South and Central America.

AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD

,